Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.19.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2019
Mar. 31, 2018
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 895,000 $ 512,000
Short term debt, issuance costs 0 205,000
Long term debt, issuance costs and discounts $ 0 $ 1,827,000
Series A convertible preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Series A convertible preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Series A convertible preferred stock, shares issued (in shares) 100,000 100,000
Series A convertible preferred stock, shares outstanding (in shares) 100,000 100,000
Series A convertible preferred stock, liquidation preference $ 1,000,000 $ 1,000,000
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 200,000,000 200,000,000
Common stock, issued (in shares) 82,354,940 76,843,278
Common stock, outstanding (in shares) 81,620,484 76,108,822
Treasury Stock (in shares) 754,599 754,599